Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions

This publication has 53 references indexed in Scilit:

• Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
  Vaccine, 2008
• Association of Serotypes of Streptococcus pneumoniae with Disease Severity and Outcome in Adults: An International Study
  Clinical Infectious Diseases, 2007
• Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries
  European Journal of Clinical Microbiology & Infectious Diseases, 2007
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
  Clinical Infectious Diseases, 2007
• The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven‐Valent Pneumococcal Conjugate Vaccine
  Canadian Journal of Infectious Diseases and Medical Microbiology, 2006
• Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race
  Annals of Internal Medicine, 2003
• Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries
  Clinical Infectious Diseases, 2000
• Is Streptococcus Pneumoniae the leading cause of pneumonia of unknown etiology? a microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia
  The American Journal of Medicine, 1999
• Community-acquired pneumonia
  The Lancet, 1998
• Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
  Published by American Medical Association (AMA) ,1997